Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solu-medrol for Postmastectomy Seroma Prevention
NCT00307606Phase 4Unknown
- Sponsor
- Herlev Hospital
- Start
- Dec 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone sodium succinate in Seroma, sponsored by Herlev Hospital. Status: unknown.
02
Drugs
methylprednisolone sodium succinate
03
Conditions
Seroma
Beyond the preview
Go deeper on NCT00307606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307606.